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Seyed Mohammad Kalantar Motamedi1, Reza Majdzadeh2, Fatemeh Ardeshir Larijani1, Fakher Raheem1,
Zahra Koleini3 and Bagher Larijani1*Abstract
Background: Increasing diabetes incidence demands investigation of risk factors, prioritization and designing
modification interventions. We calculated the potential modifiable incidence of diabetes due to reduction in risk
factors.
Methods: We used counterfactual analysis model to estimate avoidable burden of incident diabetes related to
each risk factor. The potential impact fraction (PIF) index calculated utilizing the data of current prevalence,
magnitude of impact and counterfactual status of risk factors. We considered the levels of evidence while giving
higher priority to domestic data.
Results: The estimated PIF regarding minimum feasible risk for the impaired fasting glucose (IFG), impaired glucose
tolerance (IGT), combined IFG/IGT, low HDL, high triglyceride, high total cholesterol, hypertension, general obesity,
central obesity and physical inactivity were 0.13, 0.10, 0.18, 0.01, 0.12, 0.03, 0.13, 0.03, 0.02 and 0.10, respectively.
Conclusion: While the combined risk factors of IFG and IGT should be noticed as the most important potential
factor in prevention of diabetes and reducing its incidence burden, among the other risk factors, modification of
hypertension, high triglyceride, and physical inactivity could have more impact.
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Diabetes is considered as one of the top 10 leading
causes of death in middle-income countries, it has
reached to seventh place in the high-income countries
[1]. According to the International Diabetes Foundation
285 million people are diabetics worldwide, that will rise
to 438 million by 2030 [1].This increase in the diabetes
incidence in African and Middle-East countries are more
than the industrialized countries [1]. In Iran the burden
of diabetes was calculated about 306440 years in year
2000 [2]. It has been estimated that the prevalence of
diabetes will rise from 8% to 9.8%, from 2010 to 2030
[1]. This fact represents an increased effect of costs of
diabetes in the future. Therefore, due to numerous and
costly complications of diabetes, designing suitable inter-
ventions to control this process would be necessary. To* Correspondence: larijani@tums.ac.ir
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distribution, and reproduction in any mediumdesign more effective or efficient interventions and
prioritize them, the preventive health systems programs,
should calculate an indicator called potential impact
fraction (PIF) of risk factors. The counterfactual analysis
model was introduced as a suitable estimation of modifi-
cation for incident disease prior to preventive interven-
tions [3]. This index predicts the rate of change in
incidence of disease following a change in any of the risk
factors.
Counterfactual analysis model, which has shown its
efficiency in the analysis of disease risk factors in global
burden study, is a suitable basis for prioritization of
preventive health systems programs. In this model, the
current situation of the risk factor (prevalence) is called
factual, the target condition of that factor (target preva-
lence for the health system) is called counterfactual [4-8],
and avoidable burden of the disease which is obtained via
primary preventive programs (reducing the prevalence of
risk factor) is called PIF [3,4,7-12]. In order to calculateed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 The prevalence of diabetes risk factors in Iran,
Esteghamati et al. (17)
Prevalence % (95% CI) Variable
16.8(16.4-17.2) IFG(mg/dl)
22.3(20.2-24.5) General obesity (cm)






IFG: Impaired Plasma glucose. IFG: 100 ≤ FPG < 126 mg/dl.
Hypertriglyceridemia: TG > 250 mg/dl.
HDL: High- Density Lipoprotein. Low HDL in male: HDL < 35 mg/dl .Low HDL in
female: HDL < 45 mg/dl.
Hypercholesterolemia: T-Chol > 200 mg/dl.
Central obesity: Female WC > 80, Male WC > 94 cm.
General Obesity: Body Mass Index (BMI) ≥30 kg/m2.
Hypertension: SBP ≥ 140 or DBP ≥ 90 mmHg.
Physical inactivity: ≤ 1 time exercise during the week.
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and counterfactual are required.
The counterfactual can fall into one of the four condi-
tions including theoretical minimum risk level, minimum
level of reasonable risk, feasible minimum risk levels or
minimum levels of cost-effectiveness. We, however, selected
only the feasible minimum risk levels.
This review aimed to determine the PIF of the risk
factors in preventing and reducing the diabetes burden.
Methods
Definition of variables
The risk factors for diabetes included in this study were
impaired fasting glucose (IFG: 100 ≤ FPG <126 mg / dl)
[13], high triglycerides (TG > 250 mg / dl) [14], impaired
glucose tolerance test (IGT: 140 ≤ 2hPG <200 mg / dl),
low HDL (HDL <35 mg / dl for male subjects and HDL
<45 mg / dl for females) [14], high total cholesterol
(> 200 mg / dl T-Chol), abdominal obesity (WC > 80 in
women and WC>94 in men) [14] ,general obesity (BMI≥ 30)
[15], hypertension (SBP≥ 140 or DBP ≥ 90) [16], physical ac-
tivity (intensive exercise of less than once a week). To cal-
culate the PIF of each risk factor, those studies were
selected that used same definition and criterion of the
variables of interest.
Search strategy and data sources
We searched MEDLINE, EMBASE, SID (Scientific Infor-
mation Database) and Scopus. The selected search
engines searched using specific keywords such as Potential
Impact Fraction (PIF), diabetes risk factors, diabetes
prevention, generalized impact fraction, Iran, burden of
the diabetes, dyslipidemia, hypertriglyceridemia, hyper-
cholesterolemia, impaired glucose tolerance, impaired
fasting glucose and other terms for risk factors. The
general keywords included metabolic syndrome, burden of
diseases, prevention, modifiable risk factors and their
combinations.
Study selection
Eligible studies were life-style modifying interventions
that enrolled normal subjects of Iranian population. To
determine the counterfactual prevalence of risk factors,
firstly, local interventional studies that succeed to reduce
the prevalence of risk factors were studied. However, in
case of the absence of local studies, global literatures
were used. The priority was given to those studies with
the highest level of internal and external validity.
Calculations
The data gathered from eligible studies was used to
calculate the potential impact fraction for each diabetes
risk factors. Prevalence of risk factors, the magnitude of
their effect on increasing the risk of incidence diabetesin terms of odds ratios of relative risks and the feasible
counterfactual state of the risk factor frequency was
obtained and entered into the PIF formula as mentioned
in the Appendix.
Results
We used the data of Third national surveillance of risk
factors of non-communicable diseases (SuRFNCD-2007)
[17] to determine the prevalence of diabetes risk factors
(Table 1). 4233 people aged between 25 and 64 were
selected in a randomized cluster sampling from all the
provinces of the country and the sample size was pro-
portionate to total population for each province. We also
extracted the odds ratios of each risk factor for diabetes.
The fact that our study was a cross-sectional study; we
couldn’t extract the risk of impaired glucose tolerance
and impaired fasting glucose for diabetes.
In order to find the magnitude effect of the risk factors
we extracted data of a 6-year follow-up of 3307 non
diabetics aged above 20 years performed by Harati et al.
[18]. Identification of new cases of diabetes was during
two phases of the study, first between 2001 and 2005
and second between 2005 and 2008. The criteria for
diabetes were adopted from American Diabetes Association
definition. Definitions for risk factors with their cut-off
points and metabolic syndrome, were based on ECDCDM
2003 and IDF in 2005 respectively [19,20]).
Likewise was the study of Valdes et al. [21] which is a
6-year follow-up of 1034 people of age 30 to 75. The
results are summarized in Table 2.
We also searched for domestic studies in order to
determine the counterfactual status of each risk factor.
The only found prospective intervention for modifica-
tion of risk factors was by Harati et al. in year 2010. The
Table 2 Magnitude of the effect of risk factors on the incident of diabetes
Risk factor OR Esteghamati et al. OR Harati et al. (18) Adjusted OR -
Harati et al. (18)
OR - Valdez et al. (21) Adjusted OR -
Valdez (21)
IFG - 8.3 (4.2–16.5) 7.4 (3.6–15.0) 11.5 (5.6–23.6) 8.4 (3.1–23)
IGT - 7.1 (5.1–9.8) 5.9 (4.2–8.4) 6.7 (3.4–13.3) 4.7 (1.9–11.7)
IFG + IGT - 42.2 (25.8–75.7) 42.2 (23.8–74.9) 45.6 (15.8–131.4) 45.6 (15.8–131.4)
General Obesity 2.04(2.48-1.66) 4.0 (2.7–5.8) 2.3 (1.5–3.6) 6.1 (2–18.8) -
Central Obesity 1.97(1.61-2.33) 1.4 (1.3–1.5) 1.9 (1.4–2.6) - -
Hypercholesterolemia 1.99(1.61-2.45) - - 1.6 (0.8–3) -
Hypertriglyceridemia 2.75(2.14-3.53) 2.0 (1.5–2.6) $ 1.4 (1.1–1.9) 4.8 (2.2–10.4) -
Low HDL 1.19(0.97-1.46) 1.4 (1.0–1.9) - 2.9 (1.5–5.6) -
Hypertension - 1.9 (1.4–2.6) - 4 (2.1–7.9) -
Physical Inactivity 1.5(1.24-1.82) - - 2.7 (1.4–5.1)
IFG: Impaired Plasma glucose. 100 ≤ FPG <126 mg/dl.
IGT: Impaired glucose tolerance. 140 < Two-hour glucose levels ≤199 mg /dl.
Hypertriglyceridemia: TG > 250 mg/dl.
HDL: High- Density Lipoprotein. Low HDL in male: HDL < 35 mg/dl .Low HDL in female: HDL < 45 mg/dl.
Hypercholesterolemia: T-Chol > 200 mg/dl.
Central obesity: Female WC > 80, Male WC > 94 cm.
General Obesity: Body Mass Index (BMI) ≥30 kg/m2.
Hypertension: SBP ≥ 140 or DBP ≥ 90 mmHg.
Physical inactivity: ≤ 1 time exercise during the week.
Table 3 Estimation of reduction in prevalence of high risk
population in Iran, based on counterfactual minimum
risk extracted from the study of Lindstrom et al
Risk factor Reduction % (95% CI)
General Obesity 12% (10.3-13)
Central Obesity 10% (8.8-11.0)
IFG 8% (7.3-8.7)
IGT 21% (19.7- 22.1)
Hypercholesterolemia 10% (9.1- 10.6)
Hypertriglyceridemia 40% (38.2 – 43.5)
Low HDL 13% (12.1 – 14.3)
Physical Inactivity 60% (54.5 – 63.2)
IFG: Impaired Plasma glucose. 100 ≤ FPG <126 mg/dl.
IGT: Impaired glucose tolerance. 140 < Two-hour glucose levels ≤199 mg /dl.
Hypertriglyceridemia: TG > 250 mg/dl.
HDL: High- Density Lipoprotein. Low HDL in male: HDL < 35 mg/dl .Low HDL in
female: HDL < 45 mg/dl.
Hypercholesterolemia: T-Chol > 200 mg/dl.
Central obesity: Female WC > 80, Male WC > 94 cm.
General Obesity: Body Mass Index (BMI) ≥30 kg/m2.
Hypertension: SBP ≥ 140 or DBP ≥ 90 mmHg.
Physical inactivity: ≤ 1 time exercise during the week.
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blood pressure; total cholesterol and triglyceride, while
others increased during follow up. Although they
reported the decrease in incidence of diabetes to less
than a half of that for control group, it was not the most
successful intervention for modification of all the risk
factors. Therefore we considered some non-domestic
studies.
The Finnish diabetes Prevention Study by Lindstrom
et al. [22] is a 2-year follow-up of 522 high risk subjects
for diabetes. They were randomly grouped into life style
intervention and control groups. Each subject in the
intervention group received individualized counseling
aimed at reducing weight and intake of total and satu-
rated fat and increasing intake of fiber and physical
activity. The summarized results of this study are shown
in Table 3. It should be noticed that the decrease in the
frequency of high risk subjects was not mentioned
directly but the mean decrease in the value of each fac-
tor was reported. Considering the normal distribution of
variable values in the population, we estimated the
decrease of high risk people for all the factors. We did
not find any study in which changes in high risk popula-
tion was reported, except for hypertension. Lindstrom
et al. reported the systolic and diastolic hypertension
separately, so that we were unable to estimate the true
number of hypertensive participants.
In order to estimate the possible decrease in hyperten-
sive people, in a 9 year follow up, Steinberg et al. [23],
from 1998 through 2006 reported a decline from 4675
to 3647 cases. This is equivalent to 22% reduction in
prevalence of hypertension.We also utilized the results of the PREMIER Clinical
Trial which succeeded in modifying hypertension from
38% to 12%. The subjects in this trial were not under
antihypertensive therapy. Participants were randomized
to one of 3 intervention groups: the "established," group
was a behavioral intervention that implemented estab-
lished recommendations; the “established plus DASH,"
which also implemented the DASH a diet; and an "advice
only" comparison group.
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from a study by Laaksonen et al. [24] from Finnish Diabetes
Prevention Study. They modified physical inactivity from
37% to 15%, which is about a 60% reduction in the high risk
population.
Finally the potential modifiable fraction burden of the
diabetes incident due to different risk factors was calcu-
lated (Table 4).
Discussion
Since the index of “Attributable Risk” seems inappropri-
ate to estimate the possible reduction of the disease and
gives impractical values, a more objective and oper-
ational index is necessary to check the conditions of the
disease in case of risk factors modification. The import-
ance of this study is that it is the first attempt to observe
the modifiable burden of incident diabetes by reducing
risk factors using the potential impact fraction (PIF).
Moreover, risk factors cannot completely and practically
be removed from the society, but to a certain extent are
modifiable. Therefore, the extent of feasible, plausible or
cost-effective modification minimum risk addition to
their impact should be considered. This point is the
superiority of PIF compared to the Attributable Risk
measure which presumes deletion of risk factor impact
on the outcome condition. This index can be used for
ranking risk factors based on the amount of impact that
their adjustment has on reducing the incidence of out-
comes, which consequentially prioritizes the preventiveTable 4 Calculated “Potential Impact Fractions” of risk










IFG 16.8 12.4 0.13
IGT 6.7 3.3 0.10
IFG + IGT 4.2 3.0 0.18
General Obesity 22.3 18.7 0.03
Central Obesity 53.6 50 0.02
Total Cholesterol 42.9 37.7 0.03
Triglyceride 26.7 16.2 0.12
HDL 42.7 37.1 0.01
Hypertension 26.6 8.6 0.13
Physical Inactivity 40.0 16 0.10
RF: Risk Factor.
IFG: Impaired Plasma glucose. 100 ≤ FPG <126 mg/dl.
IGT: Impaired glucose tolerance. 140 < Two-hour glucose levels ≤199 mg /dl.
Hypertriglyceridemia: TG > 250 mg/dl.
HDL: High- Density Lipoprotein. Low HDL in male: HDL < 35 mg/dl .Low HDL in
female: HDL < 45 mg/dl.
Hypercholesterolemia: T-Chol > 200 mg/dl.
Central obesity: Female WC > 80, Male WC > 94 cm.
General Obesity: Body Mass Index (BMI) ≥30 kg/m2.
Hypertension: SBP ≥ 140 or DBP ≥ 90 mmHg.
Physical inactivity: ≤ 1 time exercise during the week.interventions in health systems and would be more
objective and strategic.
In this study we investigated and determined the PIF
of each risk factor of diabetes by the amount of feasible
reduction. We can infer that modification of combined
risk factors of impaired fasting glucose and impaired
glucose tolerance is obviously the main priority of pre-
ventive interventions designed to reduce the possible in-
cident diabetes. It had the highest PIF among risk
factors on the prevention of diabetes (PIF = 0.18).The
other most frequent risk factors were impaired fasting
glucose, triglycerides, and hypertension with the PIFs of
0.13, 0.13 and 0.12, respectively. The interesting finding
based on the results of this study was that the Impact of
feasible hypertriglyceridemia modification was more
than the impaired glucose tolerance and physical inactivity
(PIF = 0.10 for both).
Moreover, the other important finding was that the
impact of hypertension (PIF = 0.13) was more than the
potential impact of obesity, general obesity, total choles-
terol, hypertriglyceridemia and HDL. However, the import-
ance of high blood pressure according to its considerable
impact on causing the cardiovascular complications in
diabetic patients should be considered.
Intervention to reduce such risk factors in the com-
munity demands various effective methods of lifestyle
modification. Any intervention should also be evaluated
according to internal validity to find out possible biases.
More over the external validity is important to be inves-
tigated in order to generalize the possible outcomes to
different conditions elsewhere.
The improvement of public awareness, encouragements,
establishing clear and specific programs, follow up by orga-
nizations and advertising are considered to be effective.
The improvement of public awareness has different useful
ways such as presentations, face to face interviews, publica-
tions, the media group, the Internet and panel discussions,
which several studies have been discussed the efficacy of
these methods previously [25,26] .
But the important point in continuation of this research
is the economic issues. Calculation of certain extent in
order to optimize the costs for maximum acceptable
results is referred as cost-effectiveness. Besides, another
issue is regarding the type of diabetes risk factors in
patients. In this regard, studies of interventional methods
beyond the lifestyle and preventive clinical interventions
should be considered. For example, controlled medica-
tions for overweight or impaired glucose conditions in
terms of cost effectiveness should be further studied and
investigated. Another issue is continuing the preventive
programs and follow-up of the people who are covered by
the program.
The estimated PIF of risk factors is discussed in various
diseases especially non-communicable types that preventive
Kalantar Motamedi et al. Journal of Diabetes & Metabolic Disorders 2012, 11:8 Page 5 of 6
http://www.jdmdonline.com/content/11/1/8methods are typically the best way to fight with them. In a
study in South Korea [27] which estimates the potential
health outcome by reducing risk factors for stroke, the
attributable burden of stroke given the current prevalence
of avoidable risk factors and counterfactual prevalence of
risk factors are calculated. The burden of stroke in terms of
its current prevalence per 100000 people for males were
1940, 4 person-years for smoking, 864.3 person-years for
alcohol and 667.3 person-years for high blood pressure. In
case of females the current prevalence per 100000 people
were 462.8 person – years for alcohol, 455.7 person – years
for physical activity and 407.7 person – years for smoking.
In conclusion, adjusted and combined risk factors of
impaired fasting glucose and impaired glucose tolerance
are the main priority of preventive interventions
designed to reduce the possible incidence of diabetes.
However, other risk factors mostly hypertension are also
not less important and should also be considered in
designing interventions. Proper implementation of these
interventions will have a significant contribution in re-
ducing the burden of incident diabetes and consequently
save money for future health system costs, particularly
in the form of national plans to prevent diabetes.
Endnotes
a The Dietary Approaches to Stop Hypertension
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RRi: Magnitude of effect
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